This brand name is authorized in Austria, Estonia, Croatia, Ireland, Lithuania, Poland
The drug DZUVEO contains one active pharmaceutical ingredient (API):
|
1
Sufentanil
UNII S9ZFX8403R - SUFENTANIL CITRATE
|
|
Sufentanil is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action), and the replacement of the phenyl ring by thiophene. The main use of this medication is in operating suites and critical care where pain relief is required for a short period of time. It also offers properties of sedation and this makes it a good analgesic component of anesthetic regimen during an operation |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DZUVEO Sublingual tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N01AH03 | Sufentanil | N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1775088, 1775099 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1085930, 1085931 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100408130 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
